{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:48:50Z","timestamp":1793620130136,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-adherence to anti-tuberculosis (anti-TB) medication is a major risk factor for poor treatment outcomes. We therefore assessed the effectiveness of medication adherence enhancing interventions in TB patients. We report a systematic review of randomized controlled trials that included either latent tuberculosis infection (LTBI) or active TB patients. Outcomes of interest included adherence rate, completed treatment, defaulted treatment and treatment outcomes. We identified four LTBI and ten active TB studies. In active TB patients, directly observed treatment (DOT) by trained community workers, short messaging service combined with education, counselling, monthly TB vouchers, drug box reminders and combinations of those were found effective. In LTBI patients, shorter regimens and DOT effectively improved treatment completion. Interestingly, DOT showed variable effectiveness, highlighting that implementation, population and setting may play important roles. Since non-adherence factors are patient-specific, personalized interventions are required to enhance the impact of a programme to improve medication adherence in TB patients.<\/jats:p>","DOI":"10.1038\/s41533-020-0179-x","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T10:03:49Z","timestamp":1589191429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-0783","authenticated-orcid":false,"given":"Ivan S.","family":"Pradipta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Houtsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job F. M.","family":"van Boven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eelko","family":"Hak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"179_CR1","unstructured":"World Health Organization. Global tuberculosis Report WHO 2018. WHO Report, Vol. 69 (WHO, 2018)."},{"key":"179_CR2","unstructured":"World Health Organization. Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care 2017 Update (World health Organization, 2017)."},{"key":"179_CR3","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJMcp021045","volume":"347","author":"RM Jasmer","year":"2002","unstructured":"Jasmer, R. M., Nahid, P. & Hopewell, P. C. Clinical practice latent tuberculosis infection. N. Engl. J. Med 347, 1860\u20131866 (2002).","journal-title":"N. Engl. J. Med"},{"key":"179_CR4","unstructured":"World Health Organization (WHO). Consolidated Guidelines on Drug-Resistant Tuberculosis Treatment (World health Organization, 2019)."},{"key":"179_CR5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1371\/journal.pmed.0040238","volume":"4","author":"SA Munro","year":"2007","unstructured":"Munro, S. A. et al. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 4, 1230\u20131245 (2007).","journal-title":"PLoS Med."},{"key":"179_CR6","first-page":"1","volume":"7","author":"AR Patel","year":"2017","unstructured":"Patel, A. R. et al. Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study. BMJ Open 7, 1\u201310 (2017).","journal-title":"BMJ Open"},{"key":"179_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5588\/ijtld.19.0301","volume":"24","author":"R Abolhassani","year":"2020","unstructured":"Abolhassani, R. et al. Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: systematic review. Int. J. Tuberc. Lung Dis. 24, 8 (2020).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"179_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jinf.2018.10.004","volume":"77","author":"IS Pradipta","year":"2018","unstructured":"Pradipta, I. S., Forsman, L. D., Bruchfeld, J., Hak, E. & Alffenaar, J. W. Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis. J. Infect. 77, 469\u2013478 (2018).","journal-title":"J. Infect."},{"key":"179_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-019-0561-z","volume":"8","author":"IS Pradipta","year":"2019","unstructured":"Pradipta, I. S., Van\u2019T Boveneind-Vrubleuskaya, N., Akkerman, O. W., Alffenaar, J. W. C. & Hak, E. Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015. Antimicrob. Resist. Infect. Control 8, 1\u201312 (2019).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"179_CR10","doi-asserted-by":"publisher","first-page":"761.e1","DOI":"10.1016\/j.cmi.2018.10.009","volume":"25","author":"IS Pradipta","year":"2019","unstructured":"Pradipta, I. S., van\u2019t Boveneind-Vrubleuskaya, N., Akkerman, O. W., Alffenaar, J. W. C. & Hak, E. Predictors for treatment outcomes among patients with drug-susceptible tuberculosis in the Netherlands: a retrospective cohort study. Clin. Microbiol. Infect. 25, 761.e1\u2013761.e7 (2019).","journal-title":"Clin. Microbiol. Infect."},{"key":"179_CR11","unstructured":"World Health Organization. Adherence to Long-Term Therapies (World Health Organization, 2003)."},{"key":"179_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1006\/pmed.2000.0673","volume":"30","author":"SL Norris","year":"2000","unstructured":"Norris, S. L., Grothaus, L. C., Buchner, D. M. & Pratt, M. Effectiveness of physician-based assessment and counseling for exercise in a staff model HMO. Prev. Med. 30, 513\u2013523 (2000).","journal-title":"Prev. Med."},{"key":"179_CR13","first-page":"170","volume":"3","author":"S Tutty","year":"2000","unstructured":"Tutty, S., Simon, G. & Ludman, E. Telephone counseling as an adjunct to antidepressant treatment in the primary care system. A pilot study. Eff. Clin. Pract. 3, 170\u2013178 (2000).","journal-title":"Eff. Clin. Pract."},{"key":"179_CR14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1345\/aph.19201","volume":"34","author":"NJ Ostrop","year":"2000","unstructured":"Ostrop, N. J., Hallett, K. A. & Gill, M. J. Long-term patient adherence to antiretroviral therapy. Ann. Pharmacother. 34, 703\u2013709 (2000).","journal-title":"Ann. Pharmacother."},{"key":"179_CR15","first-page":"1","volume":"11","author":"S Mohammed","year":"2016","unstructured":"Mohammed, S., Glennerster, R. & Khan, A. J. Impact of a daily SMS medication reminder system on tuberculosis treatment outcomes: a randomized controlled trial. PLoS ONE 11, 1\u201313 (2016).","journal-title":"PLoS ONE"},{"key":"179_CR16","first-page":"156","volume":"31","author":"RJ Farooqi","year":"2017","unstructured":"Farooqi, R. J., Ashraf, S. & Zaman, M. The role of mobile SMS-reminders in improving drugs compliance in patients receiving anti-TB treatment from DOTS program. J. Postgrad. Med. Inst. 31, 156\u2013162 (2017).","journal-title":"J. Postgrad. Med. Inst."},{"key":"179_CR17","first-page":"848","volume":"7","author":"CR MacIntyre","year":"2003","unstructured":"MacIntyre, C. R. et al. A randomised controlled clinical trial of the efficacy of family-based direct observation of anti-tuberculosis treatment in an urban, developed-country setting. Int. J. Tuberc. Lung Dis. 7, 848\u2013854 (2003).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"179_CR18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.26719\/2003.9.4.702","volume":"9","author":"A Mohan","year":"2003","unstructured":"Mohan, A., Nassir, H. & Niazi, A. Does routine home visiting improve the return rate and outcome of DOTS patients who delay treatment? East. Mediterr. Health J. 9, 702\u2013708 (2003).","journal-title":"East. Mediterr. Health J."},{"key":"179_CR19","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.12659\/MSM.904957","volume":"23","author":"XH Fang","year":"2017","unstructured":"Fang, X. H. et al. Effect of short message service on management of pulmonary tuberculosis patients in Anhui Province, China: a prospective, randomized, controlled study. Med. Sci. Monit. 23, 2465\u20132469 (2017).","journal-title":"Med. Sci. Monit."},{"key":"179_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1001876","volume":"12","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial. PLoS Med. 12, 1\u201318 (2015).","journal-title":"PLoS Med."},{"key":"179_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1001\/jama.297.4.380","volume":"297","author":"S Thiam","year":"2007","unstructured":"Thiam, S. et al. Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial. J. Am. Med. Assoc. 297, 380\u2013386 (2007).","journal-title":"J. Am. Med. Assoc."},{"key":"179_CR22","first-page":"921","volume":"13","author":"M Clarke","year":"2009","unstructured":"Clarke, M., Dick, J., Zwarenstein, M., Lombard, C. J. & Diwan, V. K. Lay health worker intervention with choice of DOT superior to standard TB care for farm dwellers in South Africa: a cluster randomised control trial. Int. J. Tuberc. Lung Dis. 13, 921 (2009).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"179_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-14-154","volume":"14","author":"E Lutge","year":"2013","unstructured":"Lutge, E., Lewin, S., Volmink, J., Friedman, I. & Lombard, C. Economic support to improve tuberculosis treatment outcomes in South Africa: a pragmatic cluster-randomized controlled trial. Trials 14, 1\u201313 (2013).","journal-title":"Trials"},{"key":"179_CR24","doi-asserted-by":"publisher","first-page":"689","DOI":"10.7326\/M17-1150","volume":"167","author":"R Belknap","year":"2017","unstructured":"Belknap, R. et al. Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection. Ann. Intern. Med. 167, 689\u2013697 (2017).","journal-title":"Ann. Intern. Med."},{"key":"179_CR25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/bmj.b4248","volume":"339","author":"N Martins","year":"2009","unstructured":"Martins, N., Morris, P. & Kelly, P. M. Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste. BMJ 339, 1131 (2009).","journal-title":"BMJ"},{"key":"179_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1164\/rccm.200404-478OC","volume":"170","author":"D Menzies","year":"2004","unstructured":"Menzies, D. et al. Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months. Am. J. Respir. Crit. Care Med. 170, 445\u2013449 (2004).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"179_CR27","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.5588\/ijtld.12.0823","volume":"17","author":"Y Hirsch-Moverman","year":"2013","unstructured":"Hirsch-Moverman, Y., Colson, P. W., Bethel, J., Franks, J. & El-Sadr, W. M. Can a peer-based intervention impact adherence to the treatment of latent tuberculous infection?. Int. J. Tuberc. Lung Dis. 17, 1178\u20131185 (2013).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"179_CR28","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.2105\/AJPH.93.11.1871","volume":"93","author":"MF Hovell","year":"2003","unstructured":"Hovell, M. F. et al. Increasing Latino adolescents\u2019 adherence to treatment for latent tuberculosis infection: a controlled trial. Am. J. Public Health 93, 1871\u20131877 (2003).","journal-title":"Am. J. Public Health"},{"key":"179_CR29","first-page":"1","volume":"29","author":"J Karumbi","year":"2015","unstructured":"Karumbi, J. & Garner, P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst. Rev. 29, 1\u201345 (2015).","journal-title":"Cochrane Database Syst. Rev."},{"key":"179_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/14787210.2017.1264270","volume":"15","author":"S Valencia","year":"2017","unstructured":"Valencia, S. et al. How do we measure adherence to anti-tuberculosis treatment? Expert Rev. Anti Infect. Ther. 15, 157\u2013165 (2017).","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"179_CR31","doi-asserted-by":"publisher","unstructured":"Zijp, T. R., Mol, P. G. M., Touw, D. J. & van Boven, J. F. M. Smart medication adherence monitoring in clinical drug trials: a prerequisite for personalised medicine? EClinicalMedicine https:\/\/doi.org\/10.1016\/j.eclinm.2019.08.013 (2019).","DOI":"10.1016\/j.eclinm.2019.08.013"},{"key":"179_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2018-001018","volume":"3","author":"R Subbaraman","year":"2018","unstructured":"Subbaraman, R. et al. Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities. BMJ Glob. Health 3, e001018 (2018).","journal-title":"BMJ Glob. Health"},{"key":"179_CR33","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jclinepi.2018.12.003","volume":"108","author":"SD Alfian","year":"2019","unstructured":"Alfian, S. D., Pradipta, I. S., Hak, E. & Denig, P. A systematic review of measures estimates adherence and persistence to multiple medications. J. Clin. Epidemiol. 108, 44\u201353 (2019).","journal-title":"J. Clin. Epidemiol."},{"key":"179_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2471\/BLT.06.038927","volume":"85","author":"TR Friedena","year":"2007","unstructured":"Friedena, T. R. & Sbarbarob, J. A. Promoting adherence to treatment for tuberculosis: the importance of direct observation. Bull. World Health Organ. 85, 407\u2013409 (2007).","journal-title":"Bull. World Health Organ."},{"key":"179_CR35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J. Clin. Epidemiol. 62, 1006\u20131012 (2009).","journal-title":"J. Clin. Epidemiol."},{"key":"179_CR36","unstructured":"World Health Organization. Definitions and Reporting Framework for Tuberculosis \u2013 2013 Revision (Updated December 2014) (World health Organization, 2013)."},{"key":"179_CR37","doi-asserted-by":"publisher","unstructured":"Vrijens, B. et al. What we mean when we talk about adherence in respiratory medicine. J. Allergy Clin. Immunol. Pract. https:\/\/doi.org\/10.1016\/j.jaip.2016.05.019 (2016).","DOI":"10.1016\/j.jaip.2016.05.019"},{"key":"179_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/S0197-2456(99)00026-4","volume":"20","author":"HD Clark","year":"1999","unstructured":"Clark, H. D. et al. Assessing the quality of randomized trials: reliability of the Jadad scale. Control. Clin. Trials 20, 448\u2013452 (1999).","journal-title":"Control. Clin. Trials"}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-020-0179-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-020-0179-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-020-0179-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T03:20:22Z","timestamp":1670296822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-020-0179-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["179"],"URL":"https:\/\/doi.org\/10.1038\/s41533-020-0179-x","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"9 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}